Kashiv Bioscience’s 125,000 sq. ft. The R&D facility contains state-of-the-art analytical labs for characterization, stability, bioassay development, process development, and small-scale manufacturing of complex proteins for biosimilars. This site also conducts R&D for prodrugs and 505(b)(2) programs.
© Copyright Brinda Pharma Technologies 2023. All Rights Reserved
